Matjaž Brvar

774 total citations
19 papers, 659 citations indexed

About

Matjaž Brvar is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Matjaž Brvar has authored 19 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Organic Chemistry and 8 papers in Toxicology. Recurrent topics in Matjaž Brvar's work include Cancer therapeutics and mechanisms (12 papers), Bioactive Compounds and Antitumor Agents (8 papers) and Synthesis and biological activity (6 papers). Matjaž Brvar is often cited by papers focused on Cancer therapeutics and mechanisms (12 papers), Bioactive Compounds and Antitumor Agents (8 papers) and Synthesis and biological activity (6 papers). Matjaž Brvar collaborates with scholars based in Slovenia, Denmark and Finland. Matjaž Brvar's co-authors include Tom Šolmajer, Andrej Perdih, Gregor Anderluh, M. Renko, Vito Türk, D. Kikelj, Janez Ilaš, Päivi Tammela, Lucíja Peterlin Mašič and Tihomir Tomašič and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Matjaž Brvar

19 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matjaž Brvar Slovenia 13 434 356 156 90 65 19 659
Lyubov G. Dezhenkova Russia 18 417 1.0× 334 0.9× 170 1.1× 50 0.6× 75 1.2× 52 701
Renáta Minorics Hungary 19 438 1.0× 377 1.1× 95 0.6× 11 0.1× 92 1.4× 57 823
Gaurava Srivastava India 11 193 0.4× 153 0.4× 25 0.2× 77 0.9× 36 0.6× 37 490
Ravikumar Akunuri India 10 224 0.5× 305 0.9× 32 0.2× 25 0.3× 39 0.6× 22 455
Venkatasubramanian Ulaganathan India 16 346 0.8× 280 0.8× 15 0.1× 69 0.8× 60 0.9× 38 712
Mohammed A. Khedr Egypt 22 325 0.7× 781 2.2× 56 0.4× 14 0.2× 102 1.6× 59 1.1k
Anna‐Maria Katsori Greece 11 209 0.5× 182 0.5× 33 0.2× 70 0.8× 32 0.5× 13 445
Alexandra L. Zakharenko Russia 20 719 1.7× 332 0.9× 190 1.2× 20 0.2× 224 3.4× 51 910
Ahmed Sabt Egypt 13 244 0.6× 411 1.2× 43 0.3× 10 0.1× 59 0.9× 31 600
Mahamadhanif S. Shaikh South Africa 11 185 0.4× 390 1.1× 34 0.2× 15 0.2× 50 0.8× 25 562

Countries citing papers authored by Matjaž Brvar

Since Specialization
Citations

This map shows the geographic impact of Matjaž Brvar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matjaž Brvar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matjaž Brvar more than expected).

Fields of papers citing papers by Matjaž Brvar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matjaž Brvar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matjaž Brvar. The network helps show where Matjaž Brvar may publish in the future.

Co-authorship network of co-authors of Matjaž Brvar

This figure shows the co-authorship network connecting the top 25 collaborators of Matjaž Brvar. A scholar is included among the top collaborators of Matjaž Brvar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matjaž Brvar. Matjaž Brvar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Brvar, Matjaž, Thomas J. O’Neill, Oliver Plettenburg, & Daniel Krappmann. (2025). An updated patent review of MALT1 inhibitors (2021–present). Expert Opinion on Therapeutic Patents. 35(6). 639–656. 3 indexed citations
2.
Quon, Tezz, Eugenia Sergeev, Matjaž Brvar, et al.. (2020). Structure–Activity Relationship Studies of Tetrahydroquinolone Free Fatty Acid Receptor 3 Modulators. Journal of Medicinal Chemistry. 63(7). 3577–3595. 7 indexed citations
3.
Larsen, Olav, Michael Lückmann, Wijnand J. C. van der Velden, et al.. (2019). Selective Allosteric Modulation of N-Terminally Cleaved, but Not Full Length CCL3 in CCR1. ACS Pharmacology & Translational Science. 2(6). 429–441. 2 indexed citations
4.
Trauelsen, Mette, et al.. (2018). Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1. Scientific Reports. 8(1). 10010–10010. 16 indexed citations
5.
Jakopin, Žiga, Janez Ilaš, Michaela Barančoková, et al.. (2017). Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors. European Journal of Medicinal Chemistry. 130. 171–184. 51 indexed citations
6.
Trauelsen, Mette, Siv A. Hjorth, Matjaž Brvar, et al.. (2017). Receptor structure-based discovery of non-metabolite agonists for the succinate receptor GPR91. Molecular Metabolism. 6(12). 1585–1596. 46 indexed citations
7.
Brvar, Matjaž, et al.. (2017). 3‐substituted‐1 H ‐indazoles as Catalytic Inhibitors of the Human DNA Topoisomerase IIα. ChemistrySelect. 2(1). 480–488. 10 indexed citations
8.
Cotman, Andrej Emanuel, Matjaž Brvar, D. Kikelj, et al.. (2017). Design, Synthesis, and Evaluation of Novel Tyrosine‐Based DNA Gyrase B Inhibitors. Archiv der Pharmazie. 350(8). 10 indexed citations
9.
Larsen, Olav, Anne Steen, Matjaž Brvar, et al.. (2016). Molecular Mechanism of Action for Allosteric Modulators and Agonists in CC-chemokine Receptor 5 (CCR5). Journal of Biological Chemistry. 291(52). 26860–26874. 12 indexed citations
10.
Zidar, Nace, Tihomir Tomašič, Matjaž Brvar, et al.. (2016). New N -phenyl-4,5-dibromopyrrolamides and N -Phenylindolamides as ATPase inhibitors of DNA gyrase. European Journal of Medicinal Chemistry. 117. 197–211. 29 indexed citations
11.
Ilaš, Janez, et al.. (2016). Linker-switch approach towards new ATP binding site inhibitors of DNA gyrase B. European Journal of Medicinal Chemistry. 125. 500–514. 13 indexed citations
12.
Zidar, Nace, Tihomir Tomašič, Matjaž Brvar, et al.. (2015). N-Phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATP Competitive DNA Gyrase B Inhibitors: Design, Synthesis, and Evaluation. Journal of Medicinal Chemistry. 58(15). 6179–6194. 49 indexed citations
13.
Tomašič, Tihomir, Sotirios Katsamakas, Žiga Hodnik, et al.. (2015). Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site. Journal of Medicinal Chemistry. 58(14). 5501–5521. 92 indexed citations
14.
15.
Brvar, Matjaž, et al.. (2014). Monocyclic 4-amino-6-(phenylamino)-1,3,5-triazines as inhibitors of human DNA topoisomerase IIα. Bioorganic & Medicinal Chemistry Letters. 24(24). 5762–5768. 27 indexed citations
16.
Perdih, Andrej, Matjaž Brvar, Ana Kroflič, et al.. (2013). Discovery of the first inhibitors of bacterial enzyme d-aspartate ligase from Enterococcus faecium (Aslfm). European Journal of Medicinal Chemistry. 67. 208–220. 19 indexed citations
17.
Brvar, Matjaž, Andrej Perdih, M. Renko, et al.. (2012). Structure-Based Discovery of Substituted 4,5′-Bithiazoles as Novel DNA Gyrase Inhibitors. Journal of Medicinal Chemistry. 55(14). 6413–6426. 154 indexed citations
18.
Brvar, Matjaž, Andrej Perdih, Vesna Hodnik, et al.. (2012). In silico discovery and biophysical evaluation of novel 5-(2-hydroxybenzylidene) rhodanine inhibitors of DNA gyrase B. Bioorganic & Medicinal Chemistry. 20(8). 2572–2580. 35 indexed citations
19.
Brvar, Matjaž, Andrej Perdih, Marko Oblak, Lucíja Peterlin Mašič, & Tom Šolmajer. (2009). In silico discovery of 2-amino-4-(2,4-dihydroxyphenyl)thiazoles as novel inhibitors of DNA gyrase B. Bioorganic & Medicinal Chemistry Letters. 20(3). 958–962. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lyubov G. Dezhenkova Breakdown of academic impact, for papers by Renáta Minorics Breakdown of academic impact, for papers by Gaurava Srivastava Breakdown of academic impact, for papers by Ravikumar Akunuri Breakdown of academic impact, for papers by Venkatasubramanian Ulaganathan Breakdown of academic impact, for papers by Mohammed A. Khedr Breakdown of academic impact, for papers by Anna‐Maria Katsori Breakdown of academic impact, for papers by Alexandra L. Zakharenko Breakdown of academic impact, for papers by Ahmed Sabt Breakdown of academic impact, for papers by Mahamadhanif S. Shaikh
Rankless by CCL
2026